We are live on
!
Find out more
Federated Hermes Portfolio holdings
AUM
$61.5B
1-Year Est. Return
30.7%
This Fund
S&P 500
This Quarter
Est. Return
+5%
1 Year Est. Return
+30.7%
3 Year Est. Return
+96.89%
5 Year Est. Return
+121.97%
10 Year Est. Return
+542.41%
AUM
$40.3B
AUM Growth
+$535M
(+1.3%)
Cap. Flow
-$468M
Cap. Flow
% of AUM
-1.16%
Top 10 Holdings %
Top 10 Hldgs %
15.78%
Holding
2,279
New
170
Increased
711
Reduced
1,071
Closed
189
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Amgen
AMGN
|
+$178M |
| 2 |
LyondellBasell Industries
LYB
|
+$133M |
| 3 |
AT&T
T
|
+$124M |
| 4 |
Stanley Black & Decker
SWK
|
+$101M |
| 5 |
Pfizer
PFE
|
+$93.4M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
Clorox
CLX
|
+$229M |
| 2 |
Gilead Sciences
GILD
|
+$164M |
| 3 |
Broadcom
AVGO
|
+$149M |
| 4 |
KeyCorp
KEY
|
+$145M |
| 5 |
Darden Restaurants
DRI
|
+$125M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Healthcare | 20.21% |
| 2 | Technology | 14.44% |
| 3 | Financials | 10.84% |
| 4 | Industrials | 8.99% |
| 5 | Consumer Discretionary | 8.87% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
126
PepsiCo
PEP
$198B
| $74.8M | 0.19% |
403,831
+75,750
| +23% | +$14.1M |
|
127
CVS Health
CVS
$138B
| $74.8M | 0.19% |
1,081,563
+281,561
| +35% | +$20M |
|
128
Prologis
PLD
$135B
| $73.6M | 0.18% |
599,912
-98,264
| -14% | -$12.1M |
|
129
Steris
STE
$22.8B
| $73.4M | 0.18% |
326,149
+658
| +0.2% | +$132K |
|
|
130
Broadcom
AVGO
$1.77T
| $71.9M | 0.18% |
829,410
-2,090,980
| -72% | -$149M |
|
131
Realty Income
O
$61.4B
| $71.7M | 0.18% |
1,199,820
-15,230
| -1% | -$929K |
|
132
Automatic Data Processing
ADP
$112B
| $71.3M | 0.18% |
324,351
-50,915
| -14% | -$11M |
|
133
Apollo Global Management
APO
$69.4B
| $71.3M | 0.18% |
928,071
+155,871
| +20% | +$10.4M |
|
134
Ameriprise Financial
AMP
$48.2B
| $70.6M | 0.18% |
212,520
+30,438
| +17% | +$9.36M |
|
135
Americold
COLD
$4.2B
| $70M | 0.17% |
2,167,814
-15,986
| -0.7% | -$476K |
|
136
Brunswick
BC
$5.2B
| $70M | 0.17% |
808,127
-16,630
| -2% | -$1.36M |
|
137
Weyerhaeuser
WY
$17.6B
| $70M | 0.17% |
2,088,565
-35,508
| -2% | -$1.07M |
|
|
B
138
Barrick Mining
B
$59.8B
| $69.7M | 0.17% |
4,118,100
+1,441,700
| +54% | +$26.3M |
|
|
MRUS
139
DELISTED
Merus
MRUS
| $69.5M | 0.17% |
2,638,700
| – | – |
|
140
LKQ Corp
LKQ
$6.79B
| $69.5M | 0.17% |
1,192,229
-104,449
| -8% | -$5.81M |
|
141
Idexx Laboratories
IDXX
$45B
| $69.1M | 0.17% |
137,674
+13,547
| +11% | +$6.49M |
|
142
Simpson Manufacturing
SSD
$7.86B
| $68.3M | 0.17% |
493,462
-80,729
| -14% | -$9.92M |
|
143
Comfort Systems
FIX
$53.4B
| $68.3M | 0.17% |
416,206
+69,047
| +20% | +$10.3M |
|
144
West Pharmaceutical
WST
$23.5B
| $68.2M | 0.17% |
178,272
-4,339
| -2% | -$1.55M |
|
145
GXO Logistics
GXO
$5.92B
| $68.1M | 0.17% |
1,084,479
+237,166
| +28% | +$13.3M |
|
146
Fortinet
FTNT
$107B
| $67.8M | 0.17% |
897,268
+396,984
| +79% | +$27M |
|
147
Allegro MicroSystems
ALGM
$7.93B
| $67M | 0.17% |
1,484,920
-92,243
| -6% | -$3.73M |
|
148
Weibo
WB
$1.99B
| $65.1M | 0.16% |
4,964,288
+916,375
| +23% | +$14.6M |
|
149
ExxonMobil
XOM
$654B
| $64.9M | 0.16% |
604,994
-86,586
| -13% | -$9.45M |
|
150
Silicon Laboratories
SLAB
$7.17B
| $64.8M | 0.16% |
410,959
-9,944
| -2% | -$1.5M |
|
Similar funds
Federated Hermes's Q2 2023 Portfolio in Review
As of Q2 2023, Federated Hermes held 2,279 positions worth $40.3B, up 1.3% from $39.7B the previous quarter. Its ten largest holdings account for 16% of the portfolio.
Federated Hermes's Q2 2023 filing shows 170 new, 711 increased, 1,071 reduced and 189 closed positions. Its largest new stake was HashiCorp, Inc. Class A Common Stock: 1,317,400 shares worth $34.5M. The largest sale was Clorox, an estimated $229M.
By sector, the portfolio is most concentrated in Healthcare at 20% of assets, up from 20% a quarter earlier, followed by Technology and Financials.
- Federated Hermes's largest Q2 2023 buy was HashiCorp, Inc. Class A Common Stock: 1,317,400 shares worth $34.5M.
- Federated Hermes added most to Amgen in Q2 2023, an estimated $178M increase.
- Federated Hermes's biggest Q2 2023 reduction was Clorox, cutting an estimated $229M.
- Federated Hermes fully exited Prometheus Biosciences, Inc. Common Stock in Q2 2023, selling an estimated $55.4M.
- Federated Hermes's ten largest holdings make up 16% of its $40.3B portfolio in Q2 2023.
- Federated Hermes opened 170 new positions and closed 189 in Q2 2023.
- Federated Hermes's portfolio value rose 1.3% quarter-over-quarter to $40.3B.
Based on Federated Hermes's 13F filing for Q2 2023, filed 14 Aug 2023.